Editorial. Comments on the therapeutic implications of the Heart Outcomes Prevention Evaluation (HOPE) study for patients with diabetes. Cardiovascular complications of diabetes; Effects of ramipril, an angiotensin converting enzyme (ACE) inhibitors, on cardiovascular outcomes in high-risk patients with symptomatic vascular disease or diabetes.